1. Home
  2. EHTH vs HURA Comparison

EHTH vs HURA Comparison

Compare EHTH & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHTH
  • HURA
  • Stock Information
  • Founded
  • EHTH 1997
  • HURA 2009
  • Country
  • EHTH United States
  • HURA United States
  • Employees
  • EHTH N/A
  • HURA N/A
  • Industry
  • EHTH Specialty Insurers
  • HURA
  • Sector
  • EHTH Finance
  • HURA
  • Exchange
  • EHTH Nasdaq
  • HURA Nasdaq
  • Market Cap
  • EHTH 105.1M
  • HURA 126.1M
  • IPO Year
  • EHTH 2006
  • HURA N/A
  • Fundamental
  • Price
  • EHTH $3.85
  • HURA $2.43
  • Analyst Decision
  • EHTH Buy
  • HURA Strong Buy
  • Analyst Count
  • EHTH 4
  • HURA 2
  • Target Price
  • EHTH $8.50
  • HURA $11.50
  • AVG Volume (30 Days)
  • EHTH 268.4K
  • HURA 237.9K
  • Earning Date
  • EHTH 11-05-2025
  • HURA 11-13-2025
  • Dividend Yield
  • EHTH N/A
  • HURA N/A
  • EPS Growth
  • EHTH N/A
  • HURA N/A
  • EPS
  • EHTH N/A
  • HURA N/A
  • Revenue
  • EHTH $547,491,000.00
  • HURA N/A
  • Revenue This Year
  • EHTH $4.99
  • HURA N/A
  • Revenue Next Year
  • EHTH $3.41
  • HURA N/A
  • P/E Ratio
  • EHTH N/A
  • HURA N/A
  • Revenue Growth
  • EHTH 16.19
  • HURA N/A
  • 52 Week Low
  • EHTH $3.18
  • HURA $1.80
  • 52 Week High
  • EHTH $11.36
  • HURA $8.40
  • Technical
  • Relative Strength Index (RSI)
  • EHTH 49.68
  • HURA 43.35
  • Support Level
  • EHTH $3.82
  • HURA $2.35
  • Resistance Level
  • EHTH $4.09
  • HURA $2.64
  • Average True Range (ATR)
  • EHTH 0.20
  • HURA 0.17
  • MACD
  • EHTH -0.00
  • HURA -0.03
  • Stochastic Oscillator
  • EHTH 23.81
  • HURA 22.03

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: